Rifamycins - Rifamycins differ from the previously mentioned compounds acting on DNA in that they specifically inhibit the function of bacterial RNA polymerase, without affecting mammalian RNA polymerase. They are produced by strains of Streptomyces mediterranei. They show good activity against gram positive bacteria and Mycobacterium tuberculosis, but are much less active against gram negative bacteria.





